ArticleJournal of medicinal chemistry2026

Structure-Based Design and Optimization of Novel, Potent and Selective Covalent FGFR2/3 Inhibitors with a Tricyclic Core.

Xuzhi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.